Long Non-Coding RNAs in Venous Thromboembolism: Where Do We Stand?

Data de publicação:

Autores da FMUP

  • Rui Manuel De Medeiros Melo Silva

    Autor

Participantes de fora da FMUP

  • Marques, IS
  • Tavares, V
  • Neto, BV
  • Mota, INR
  • Pereira, D

Abstract

Venous thromboembolism (VTE), a common condition in Western countries, is a cardiovascular disorder that arises due to haemostatic irregularities, which lead to thrombus generation inside veins. Even with successful treatment, the resulting disease spectrum of complications considerably affects the patient's quality of life, potentially leading to death. Cumulative data indicate that long non-coding RNAs (lncRNAs) may have a role in VTE pathogenesis. However, the clinical usefulness of these RNAs as biomarkers and potential therapeutic targets for VTE management is yet unclear. Thus, this article reviewed the emerging evidence on lncRNAs associated with VTE and with the activity of the coagulation system, which has a central role in disease pathogenesis. Until now, ten lncRNAs have been implicated in VTE pathogenesis, among which MALAT1 is the one with more evidence. Meanwhile, five lncRNAs have been reported to affect the expression of TFPI2, an important anticoagulant protein, but none with a described role in VTE development. More investigation in this field is needed as lncRNAs may help dissect VTE pathways, aiding in disease prediction, prevention and treatment.

Dados da publicação

ISSN/ISSNe:
1661-6596, 1661-6596

International Journal of Molecular Sciences  Multidisciplinary Digital Publishing Institute (MDPI)

Tipo:
Review
Páginas:
-

Citações Recebidas na Web of Science: 4

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • RNA; long non-coding; venous thromboembolism; deep vein thrombosis; tissue-factor-pathway inhibitor 2

Financiamento

Proyectos asociados

Previsão das readmissões dos doentes à Urgência Pediátrica: aplicação das técnicas de aprendizagem supervisionadas.

Investigador Principal: Rui Manuel de Medeiros Melo Silva

Estudo Observacional Académico (UrgPediatr) . 2019

Identificação de determinantes farmacogenómicas preditivas de resposta ao tratamento em doentes com cancro do colo do útero

Investigador Principal: Rui Manuel de Medeiros Melo Silva

Estudo Clínico Académico . 2021

Pharmacoepigenomic profile of ovarian cancer patients submitted to taxane-based chemoteherapy

Investigador Principal: Rui Manuel de Medeiros Melo Silva

Estudo Clínico Académico . 2020

Anal squamous intraepithelial lesions

Investigador Principal: Rui Manuel de Medeiros Melo Silva

Estudo Clínico Académico . 2020

Characterization of Pain and Genetic Variants Associated with Pain in Patients with Metastatic Bone Disease

Investigador Principal: Rui Manuel de Medeiros Melo Silva

Estudo Clínico Académico . 2019

Citar a publicação

Partilhar a publicação